Stocktoria

IGC Pharma, Inc. IGC

NYSE · stock · Pharmaceutical Preparations · website · IPO 2006-04-13

IGC Pharma, Inc. statistics & valuation

Market cap$27.2M
P / S21.4×
P / B4.3×
Net margin-560.3%
Return on equity-112.5%
FCF margin-386.1%
Net cash$271,000
Enterprise value USD$27.0M
Earnings yield EBIT/EV-27.6%
Return on capital-114.7%

Market cap as of 2026-07-01. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-44.10% -321.70% -81.40% -80.10% -179.60% -981.20% -3782.40% -1263.00% -966.50% -560.30% 2016201720182019202020212022202320242025
Gross margin (%)
37.60% 3.70% 2.60% 2.80% 12.60% 48.90% 48.50% 54.50% 48.70% 2016201720182019202020212022202320242025
Operating margin (%)
-45.60% -354.00% -81.60% -90.80% -168.60% -971.50% -3886.10% -1270.10% -728.50% -585.80% 2016201720182019202020212022202320242025
Return on equity (%)
-20.10% -25.40% -22.10% -12.20% -27.60% -26.90% -62.80% -77.20% -177.60% -112.50% 2016201720182019202020212022202320242025
Shares outstanding
23.3M 28.3M 30.8M 39.5M 39.5M 47.8M 51.1M 53.1M 66.7M 80.9M 2016201720182019202020212022202320242025
Net debt ($)
-$689226 -$85920 -$7.3M -$14.3M -$10.3M -$3.1M -$1.1M -$271000 2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
-14.90% -16.50% -16.50% -11.90% -25.20% -24.60% -56.00% -67.00% -131.30% -81.40% 2016201720182019202020212022202320242025
Free cash flow margin (%)
-4.40% -264.80% -94.30% -65.40% -320.90% -1366.40% -1939.00% -807.60% -396.80% -386.10% 2016201720182019202020212022202320242025
Debt / equity (×)
0.06× 0.06× 0.00× 0.01× 0.01× 0.01× 0.02× 0.02× 2016201720182019202020212022202320242025
EPS ($)
-$0.17 -$0.07 -$0.22 -$0.09 2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Gross margin48.7%54.5%48.5%48.9%12.6%2.8%2.6%3.7%37.6%—
Operating margin-585.8%-728.5%-1270.1%-3886.1%-971.5%-168.6%-90.8%-81.6%-354.0%-45.6%
Net margin-560.3%-966.5%-1263.0%-3782.4%-981.2%-179.6%-80.1%-81.4%-321.7%-44.1%
FCF margin-386.1%-396.8%-807.6%-1939.0%-1366.4%-320.9%-65.4%-94.3%-264.8%-4.4%
Return on assets-81.4%-131.3%-67.0%-56.0%-24.6%-25.2%-11.9%-16.5%-16.5%-14.9%
Return on equity-112.5%-177.6%-77.2%-62.8%-26.9%-27.6%-12.2%-22.1%-25.4%-20.1%
Debt / equity0.02×0.02×0.01×0.01×0.01×0.00×——0.06×0.06×
Current ratio1.281.583.416.199.939.1230.441.372.781.20

Computed from company filings · US · as of 2025-03-31. Facts plus Stocktoria's own computed scores — not investment advice.